Biophytis (NASDAQ:BPTS) Stock Price Down 2.9%

Shares of Biophytis S.A. (NASDAQ:BPTS – Get Rating) were down 2.9% during mid-day trading on Monday . The company traded as low as $1.00 and last traded at $1.00. Approximately 200 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 29,045 shares. The stock had previously closed at $1.03.

The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 1.10. The business’s 50 day simple moving average is $1.44 and its 200-day simple moving average is $3.13.

Biophytis Company Profile (NASDAQ:BPTS)

Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases.

See Also

• Get a free copy of the StockNews.com research report on Biophytis (BPTS)
• Ride Out The Recession With These Dividend Kings 
• MarketBeat: Week in Review 6/13 – 6/17
• eBay’s Long Term Fundamentals Are Intact If You Can Stomach Short Term Volatility
• Honda’s Stock Continues To Fly Under The Radar
• Vuzix Stock Stays Optimistic

Want More Great Investing Ideas?